• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤坏死因子-α在白癜风发病机制中的作用。

The role of tumor necrosis factor-α in the pathogenesis of vitiligo.

机构信息

Departamento de Medicina Interna, Hospital Universitario "Dr. José E. González", Universidad Autónoma de Nuevo León, Madero y Gonzalitos S/N, Monterrey, NL, 64700, Mexico,

出版信息

Am J Clin Dermatol. 2013 Oct;14(5):343-50. doi: 10.1007/s40257-013-0039-3.

DOI:10.1007/s40257-013-0039-3
PMID:23912226
Abstract

Vitiligo is an acquired immune disorder of the skin characterized by the presence of white depigmented macules. Its immunopathogenesis is not completely understood, but inflammatory alterations in the skin microenvironment, and particularly increased expression of the cytokine tumor necrosis factor-α (TNFα), are thought to be essential regulators of melanocyte dysfunction and death. In this article we review the evidence that implicates TNFα in the pathogenesis of vitiligo, including studies on serum and tissue levels of TNFα, TNFα gene polymorphisms, in vitro studies, and therapeutic trials using TNFα inhibitors. TNFα emerges as a complex mediator with apparently conflicting roles in vitiligo.

摘要

白癜风是一种获得性皮肤免疫紊乱,其特征是存在白色色素减退斑。其免疫发病机制尚不完全清楚,但皮肤微环境的炎症改变,特别是细胞因子肿瘤坏死因子-α(TNFα)的表达增加,被认为是调节黑色素细胞功能障碍和死亡的重要因素。本文综述了 TNFα在白癜风发病机制中的作用的证据,包括血清和组织 TNFα水平、TNFα 基因多态性、体外研究以及 TNFα 抑制剂的治疗试验。TNFα 作为一种复杂的介质,在白癜风中表现出明显矛盾的作用。

相似文献

1
The role of tumor necrosis factor-α in the pathogenesis of vitiligo.肿瘤坏死因子-α在白癜风发病机制中的作用。
Am J Clin Dermatol. 2013 Oct;14(5):343-50. doi: 10.1007/s40257-013-0039-3.
2
A patient with psoriasis and vitiligo treated with etanercept.一位同时患有银屑病和白癜风的患者,接受了依那西普治疗。
Am J Clin Dermatol. 2010;11 Suppl 1:46-8. doi: 10.2165/1153424-S0-000000000-00000.
3
Novel approaches to vitiligo treatment via modulation of mTOR and NF-κB pathways in human skin melanocytes.通过调节人皮肤黑素细胞中的mTOR和NF-κB信号通路治疗白癜风的新方法。
Int J Biol Sci. 2017 Feb 25;13(3):391-400. doi: 10.7150/ijbs.17318. eCollection 2017.
4
Tumor Necrosis Factor-alpha affects melanocyte survival and melanin synthesis via multiple pathways in vitiligo.肿瘤坏死因子-α 通过多种途径影响白癜风中黑素细胞的存活和黑色素合成。
Cytokine. 2021 Apr;140:155432. doi: 10.1016/j.cyto.2021.155432. Epub 2021 Jan 28.
5
Autoimmunity as an aetiological factor in vitiligo.自身免疫作为白癜风的一个病因因素。
J Eur Acad Dermatol Venereol. 2007 Aug;21(7):865-76. doi: 10.1111/j.1468-3083.2007.02228.x.
6
Association of interferon-gamma and tumor necrosis factor alpha polymorphisms with susceptibility to vitiligo in Iranian patients.伊朗患者中γ-干扰素和肿瘤坏死因子α基因多态性与白癜风易感性的关联
Arch Dermatol Res. 2009 Jan;301(1):21-5. doi: 10.1007/s00403-008-0904-8. Epub 2008 Sep 27.
7
Basic fibroblast growth factor and tumour necrosis factor alpha in vitiligo and other hypopigmented disorders: suggestive possible therapeutic targets.碱性成纤维细胞生长因子和肿瘤坏死因子-α在白癜风及其他色素减退性疾病中的作用:提示可能的治疗靶点。
J Eur Acad Dermatol Venereol. 2013 Jan;27(1):103-8. doi: 10.1111/j.1468-3083.2011.04368.x. Epub 2011 Dec 8.
8
Use of anti-tumor necrosis factor agents: a possible therapy for vitiligo.抗肿瘤坏死因子药物的应用:白癜风的一种可能治疗方法。
Med Hypotheses. 2009 May;72(5):546-7. doi: 10.1016/j.mehy.2008.12.033. Epub 2009 Feb 6.
9
Endothelin-1 enhances the proliferation of normal human melanocytes in a paradoxical manner from the TNF-α-inhibited condition, but tacrolimus promotes exclusively the cellular migration without proliferation: a proposed action mechanism for combination therapy of phototherapy and topical tacrolimus in vitiligo treatment.内皮素-1 以一种矛盾的方式增强正常人类黑素细胞的增殖,使其从 TNF-α 抑制状态中恢复,但他克莫司仅促进细胞迁移而不促进增殖:这是光疗和局部他克莫司联合治疗白癜风的作用机制。
J Eur Acad Dermatol Venereol. 2013 May;27(5):609-16. doi: 10.1111/j.1468-3083.2012.04498.x. Epub 2012 Mar 9.
10
Increased Tumor Necrosis Factor (TNF)-α and its promoter polymorphisms correlate with disease progression and higher susceptibility towards vitiligo.肿瘤坏死因子 (TNF)-α 水平升高及其启动子多态性与疾病进展和白癜风的易感性增加相关。
PLoS One. 2012 Dec 20;7(12):e52298. doi: 10.1371/journal.pone.0052298.

引用本文的文献

1
The immunological pathogenesis of vitiligo and the potential role of mesenchymal stromal/stem cells in its treatment.白癜风的免疫发病机制及间充质基质/干细胞在其治疗中的潜在作用。
J Transl Med. 2025 Jul 1;23(1):707. doi: 10.1186/s12967-025-06627-8.
2
Tumor Necrosis Factor-Alpha: Ally and Enemy in Protean Cutaneous Sceneries.肿瘤坏死因子-α:变幻莫测的皮肤场景中的盟友和敌人。
Int J Mol Sci. 2024 Jul 16;25(14):7762. doi: 10.3390/ijms25147762.
3
Exploring the roles and potential therapeutic strategies of inflammation and metabolism in the pathogenesis of vitiligo: a mendelian randomization and bioinformatics-based investigation.
探索炎症和代谢在白癜风发病机制中的作用及潜在治疗策略:基于孟德尔随机化和生物信息学的研究
Front Genet. 2024 Apr 10;15:1385339. doi: 10.3389/fgene.2024.1385339. eCollection 2024.
4
Baseline Levels of Circulating Inflammatory Biomarkers Stratify Patients with Vitiligo Who Significantly Repigment after Treatment with Ruxolitinib Cream.循环炎症生物标志物的基线水平对接受鲁索替尼乳膏治疗后显著复色的白癜风患者进行分层。
JID Innov. 2023 Sep 13;3(6):100230. doi: 10.1016/j.xjidi.2023.100230. eCollection 2023 Nov.
5
Reversing Gray Hair: Inspiring the Development of New Therapies Through Research on Hair Pigmentation and Repigmentation Progress.逆转白发:通过毛发色素形成和再着色进展的研究为新疗法的开发带来启示。
Int J Biol Sci. 2023 Aug 28;19(14):4588-4607. doi: 10.7150/ijbs.86911. eCollection 2023.
6
Association of rs4711998 of IL-17A, rs2275913 of IL-17A and rs763780 IL-17F gene polymorphisms with non-segmental vitiligo in a Mexican population.白细胞介素-17A的rs4711998、白细胞介素-17A的rs2275913和白细胞介素-17F基因多态性rs763780与墨西哥人群非节段性白癜风的关联。
Arch Dermatol Res. 2023 Apr;315(3):447-454. doi: 10.1007/s00403-022-02382-8. Epub 2022 Aug 12.
7
Role of Cytokines in Vitiligo: Pathogenesis and Possible Targets for Old and New Treatments.细胞因子在白癜风中的作用:发病机制和新旧治疗方法的可能靶点。
Int J Mol Sci. 2021 Oct 22;22(21):11429. doi: 10.3390/ijms222111429.
8
Type-1 cytokines regulate MMP-9 production and E-cadherin disruption to promote melanocyte loss in vitiligo.1型细胞因子调节基质金属蛋白酶-9的产生和E-钙黏蛋白的破坏,以促进白癜风中黑素细胞的丢失。
JCI Insight. 2020 Jun 4;5(11):133772. doi: 10.1172/jci.insight.133772.
9
Therapeutic effects of iNOS inhibition against vitiligo in an animal model.诱导型一氧化氮合酶抑制对动物模型白癜风的治疗作用。
Eur J Transl Myol. 2019 Aug 6;29(3):8383. doi: 10.4081/ejtm.2019.8383. eCollection 2019 Aug 2.
10
Changes in sICAM-1 and GM-CSF levels in skin tissue fluid and expression of IL-6, IL-17 and TNF-α in blood of patients with vitiligo.白癜风患者皮肤组织液中可溶性细胞间黏附分子-1(sICAM-1)和粒细胞-巨噬细胞集落刺激因子(GM-CSF)水平的变化以及血液中白细胞介素-6(IL-6)、白细胞介素-17(IL-17)和肿瘤坏死因子-α(TNF-α)的表达
Exp Ther Med. 2019 Jan;17(1):408-412. doi: 10.3892/etm.2018.6937. Epub 2018 Nov 7.